Blood Banking Devices Market, By Product Type (Blood Collection Devices, Blood Processing Devices, Blood Storage Devices, Blood Transfusion Devices, Blood Grouping/Testing Reagents, Others), By Method of Collection (Manual Blood Collection, Automated Blood Collection), By End User (Hospitals, Clinics, Blood Banks, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Published In : Feb 2024

Code : CMI1980

Pages :182

Formats :

Excel and PDF

Industry : Medical Devices

Market News

Recent Developments

New product launches

On November 2, 2023, BD (Becton, Dickinson and Company) a medical technology company, launched new needle-free blood draw technology compatible with integrated catheters
On August 18, 2023, Nightingale Health, a medical laboratory company, launched blood collection kit for trial customers. The Nightingale kit and self-collection device enable trial participants to draw their own blood sample from a finger-prick. Nightingale Health has introduced a remote blood collection kit for its medical research and clinical trial customers.
In December 2022, Capitainer, a medical device company, launched a new product for the self-sampling of blood. The sampling card can collect five times as much blood as its predecessor. The product significantly extends Capitainer’s range and market opportunity by enabling more and other types of analyses. It is also easier for laboratories to implement.
In May 2022, Vitestro, a medical device company, launched autonomous device for blood collection. The new device combines artificial intelligence (AI) and ultrasound-guided 3D reconstruction with robotic needle insertion to ensure the precise and secure collection of blood.

Partnership and Collaboration

In May 2022, Babson Diagnostics, a science-first, health care technology company, and BD, a medical technology company, announced the expansion of a strategic partnership to move blood sample collection into new care settings, thus enabling patients to collect blood samples at home for diagnostic testing.
In April, 2022, BioIVT LLC., Biospecimens and Research Services provider company, announced that it has acquired Tennessee Blood Services, a commercial blood bank located in Memphis, U.S. Tennessee Blood Services is FDA-registered to collect whole blood and blood products for diagnostic use by manufacturers and research facilities worldwide.
On April 19, 2021, Terumo Corporation, a medical device company, CSL Plasma, a plasma collector company, announce a collaboration to deliver a new plasma collection platform at CSL Plasma U.S. collection centers.